Dual antiplatelet therapy for acute stroke and TIA: Current best practice and emerging strategies

PART 1: Chairperson’s welcome and introduction

Learning Objectives:

  • To highlight the continued high unmet need for strategies to prevent stroke or death for patients experiencing acute stroke or TIA
  • To outline the guidelines on the use of dual antiplatelet therapy for patients presenting with acute stroke or TIA
  • To examine recent evidence from clinical trials on novel strategies for improving outcomes for patients presenting with acute stroke or TIA and how these data and insights can be applied in clinical practice
Pierre Amarenco
Paris University

 


Programme Outline
  • PART 1: Chairperson’s welcome and introductionPierre Amarenco
  • PART 2: Secondary prevention after acute minor stroke or TIA: Understanding the ongoing risk Peter Rothwell
  • PART 3: Current best practice: Evidence-based antiplatelet therapy for secondary stroke preventionPierre Amarenco
  • PART 4: Evolving role of dual antiplatelet therapy for stroke prevention: Advancing best practice for patients at high risk Clay Johnston
  • PART 5: Clinical decision making for the patient presenting with acute strokePeter Schellinger
  • PART 6: Q&A and SummaryPierre AmarencoPeter RothwellClay JohnstonPeter Schellinger
The programme was supported by an unrestricted educational grant from AstraZeneca.

PART 2: Secondary prevention after acute minor stroke or TIA: Understanding the ongoing risk